Edwards Financial Ratios Analysis

EW Stock

USD 86.96 1.02 1.19%

Most ratios from Edwards Lifesciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis.

At this time, Edwards Lifesciences' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 77.16 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.

	2021	2022	2023	2024 (projected)
Dividend Yield	0.001964	0.00317	0.003673	0.003489
Price To Sales Ratio	15.43	8.58	7.7	4.36

Dividend Yield Price To Sales Ratio

Edwards Lifesciences fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Invested Capital	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		-0.55	0.97	-0.67	0.52	-0.6	-0.56	0.83	-0.72	0.97	1.0	0.77	0.73	-0.41	0.57	0.28	-0.05	-0.54	0.56	0.66	-0.02	-0.58	-0.04	0.61	-0.29	-0.29
Dividend Yield	-0.55		-0.49	0.51	-0.57	0.42	0.41	-0.58	0.4	-0.49	-0.54	-0.53	-0.3	0.3	-0.56	-0.32	0.28	0.12	-0.55	-0.59	0.01	0.95	0.02	-0.54	-0.04	0.32
Ptb Ratio	0.97	-0.49		-0.6	0.41	-0.68	-0.62	0.77	-0.82	1.0	0.97	0.7	0.77	-0.43	0.46	0.25	0.03	-0.62	0.51	0.62	-0.07	-0.49	-0.09	0.57	-0.4	-0.27
Days Sales Outstanding	-0.67	0.51	-0.6		-0.5	0.3	0.2	-0.78	0.41	-0.6	-0.67	-0.78	-0.41	0.31	-0.58	-0.25	-0.25	0.09	-0.71	-0.36	-0.07	0.66	-0.38	-0.26	0.36	0.24
Book Value Per Share	0.52	-0.57	0.41	-0.5		-0.54	-0.52	0.74	-0.3	0.41	0.52	0.65	0.34	-0.75	0.96	0.83	-0.31	0.0	0.79	0.86	0.02	-0.67	-0.15	0.79	0.12	-0.73
Free Cash Flow Yield	-0.6	0.42	-0.68	0.3	-0.54		0.94	-0.49	0.69	-0.68	-0.61	-0.4	-0.72	0.83	-0.53	-0.66	-0.15	0.37	-0.62	-0.79	-0.06	0.39	0.35	-0.75	0.53	0.74
Invested Capital	-0.56	0.41	-0.62	0.2	-0.52	0.94		-0.5	0.53	-0.62	-0.56	-0.44	-0.64	0.78	-0.56	-0.63	-0.19	0.22	-0.59	-0.72	-0.01	0.37	0.22	-0.67	0.54	0.79
Operating Cash Flow Per Share	0.83	-0.58	0.77	-0.78	0.74	-0.49	-0.5		-0.48	0.77	0.83	0.98	0.44	-0.5	0.84	0.45	-0.03	-0.17	0.77	0.62	0.03	-0.67	0.25	0.51	-0.2	-0.43
Capex To Depreciation	-0.72	0.4	-0.82	0.41	-0.3	0.69	0.53	-0.48		-0.82	-0.72	-0.35	-0.78	0.45	-0.26	-0.3	0.0	0.85	-0.44	-0.61	0.15	0.38	0.46	-0.64	0.33	0.24
Pb Ratio	0.97	-0.49	1.0	-0.6	0.41	-0.68	-0.62	0.77	-0.82		0.97	0.7	0.77	-0.43	0.46	0.25	0.03	-0.62	0.51	0.62	-0.07	-0.49	-0.09	0.57	-0.4	-0.27
Ev To Sales	1.0	-0.54	0.97	-0.67	0.52	-0.61	-0.56	0.83	-0.72	0.97		0.77	0.73	-0.42	0.57	0.28	-0.04	-0.54	0.56	0.66	-0.01	-0.57	-0.04	0.6	-0.29	-0.29
Free Cash Flow Per Share	0.77	-0.53	0.7	-0.78	0.65	-0.4	-0.44	0.98	-0.35	0.7	0.77		0.32	-0.4	0.79	0.34	0.05	-0.04	0.72	0.48	0.05	-0.63	0.43	0.35	-0.23	-0.36
Roic	0.73	-0.3	0.77	-0.41	0.34	-0.72	-0.64	0.44	-0.78	0.77	0.73	0.32		-0.59	0.33	0.45	0.0	-0.68	0.35	0.61	0.01	-0.3	-0.41	0.63	-0.39	-0.39
Inventory Turnover	-0.41	0.3	-0.43	0.31	-0.75	0.83	0.78	-0.5	0.45	-0.43	-0.42	-0.4	-0.59		-0.7	-0.95	-0.01	0.13	-0.68	-0.81	-0.07	0.34	0.32	-0.78	0.28	0.8
Net Income Per Share	0.57	-0.56	0.46	-0.58	0.96	-0.53	-0.56	0.84	-0.26	0.46	0.57	0.79	0.33	-0.7		0.75	-0.17	0.08	0.81	0.76	0.0	-0.68	0.06	0.66	-0.02	-0.75
Days Of Inventory On Hand	0.28	-0.32	0.25	-0.25	0.83	-0.66	-0.63	0.45	-0.3	0.25	0.28	0.34	0.45	-0.95	0.75		-0.18	-0.03	0.64	0.8	0.05	-0.37	-0.36	0.79	-0.03	-0.78
Payables Turnover	-0.05	0.28	0.03	-0.25	-0.31	-0.15	-0.19	-0.03	0.0	0.03	-0.04	0.05	0.0	-0.01	-0.17	-0.18		0.18	0.23	-0.29	0.08	0.16	0.45	-0.32	-0.88	-0.16
Capex To Revenue	-0.54	0.12	-0.62	0.09	0.0	0.37	0.22	-0.17	0.85	-0.62	-0.54	-0.04	-0.68	0.13	0.08	-0.03	0.18		-0.02	-0.36	0.09	0.06	0.64	-0.46	0.08	-0.1
Cash Per Share	0.56	-0.55	0.51	-0.71	0.79	-0.62	-0.59	0.77	-0.44	0.51	0.56	0.72	0.35	-0.68	0.81	0.64	0.23	-0.02		0.7	0.17	-0.7	0.1	0.63	-0.36	-0.69
Pocfratio	0.66	-0.59	0.62	-0.36	0.86	-0.79	-0.72	0.62	-0.61	0.62	0.66	0.48	0.61	-0.81	0.76	0.8	-0.29	-0.36	0.7		-0.04	-0.62	-0.48	0.98	-0.02	-0.72
Interest Coverage	-0.02	0.01	-0.07	-0.07	0.02	-0.06	-0.01	0.03	0.15	-0.07	-0.01	0.05	0.01	-0.07	0.0	0.05	0.08	0.09	0.17	-0.04		0.0	0.09	-0.04	-0.11	0.07
Payout Ratio	-0.58	0.95	-0.49	0.66	-0.67	0.39	0.37	-0.67	0.38	-0.49	-0.57	-0.63	-0.3	0.34	-0.68	-0.37	0.16	0.06	-0.7	-0.62	0.0		-0.07	-0.56	0.0	0.43
Capex To Operating Cash Flow	-0.04	0.02	-0.09	-0.38	-0.15	0.35	0.22	0.25	0.46	-0.09	-0.04	0.43	-0.41	0.32	0.06	-0.36	0.45	0.64	0.1	-0.48	0.09	-0.07		-0.61	-0.25	0.19
Pfcf Ratio	0.61	-0.54	0.57	-0.26	0.79	-0.75	-0.67	0.51	-0.64	0.57	0.6	0.35	0.63	-0.78	0.66	0.79	-0.32	-0.46	0.63	0.98	-0.04	-0.56	-0.61		0.02	-0.66
Days Payables Outstanding	-0.29	-0.04	-0.4	0.36	0.12	0.53	0.54	-0.2	0.33	-0.4	-0.29	-0.23	-0.39	0.28	-0.02	-0.03	-0.88	0.08	-0.36	-0.02	-0.11	0.0	-0.25	0.02		0.33
Income Quality	-0.29	0.32	-0.27	0.24	-0.73	0.74	0.79	-0.43	0.24	-0.27	-0.29	-0.36	-0.39	0.8	-0.75	-0.78	-0.16	-0.1	-0.69	-0.72	0.07	0.43	0.19	-0.66	0.33

Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	11.18	12.95	15.43	8.58	7.7	4.36
Dividend Yield	3.89E-4	0.002474	0.001964	0.00317	0.003673	0.003489
Ptb Ratio	11.71	12.42	13.84	7.95	6.96	4.82
Book Value Per Share	6.64	7.35	9.36	9.38	10.96	11.51
Free Cash Flow Yield	0.0185	0.0114	0.0174	0.0206	0.0136	0.0129
Invested Capital	0.19	0.16	0.15	0.12	0.1	0.0993
Pb Ratio	11.71	12.42	13.84	7.95	6.96	4.82
Ev To Sales	8.57	11.06	12.84	15.4	7.63	4.39
Inventory Turnover	1.74	1.35	1.72	1.23	1.18	1.12
Net Income Per Share	1.68	1.32	2.41	2.46	2.31	2.43
Payables Turnover	6.18	5.5	6.11	5.35	6.85	4.78
Capex To Revenue	(0.064)	(0.0929)	(0.063)	(0.0492)	(0.0443)	(0.0466)
Pocfratio	41.2	53.87	46.62	37.91	51.64	54.22
Interest Coverage	55.4	103.06	73.29	91.07	87.16	46.38
Pfcf Ratio	53.93	87.79	57.58	48.44	73.49	77.16
Pe Ratio	46.42	68.98	53.72	30.35	32.99	31.34
Ev To Free Cash Flow	53.38	87.03	57.46	48.36	72.77	76.41
Earnings Yield	0.0215	0.0145	0.0186	0.033	0.0303	0.0169
Current Ratio	3.31	3.46	3.08	3.03	3.38	2.33
Receivables Turnover	7.26	7.28	7.87	7.7	7.18	5.45

Edwards Lifesciences Investors Sentiment

The influence of Edwards Lifesciences' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Edwards. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Edwards Lifesciences' public news can be used to forecast risks associated with an investment in Edwards. The trend in average sentiment can be used to explain how an investor holding Edwards can time the market purely based on public headlines and social activities around Edwards Lifesciences Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Edwards Lifesciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Edwards Lifesciences' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Edwards Lifesciences' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Edwards Lifesciences.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Edwards Lifesciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Edwards Lifesciences' short interest history, or implied volatility extrapolated from Edwards Lifesciences options trading.

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Edwards Stock

0.84	SINT	SINTX Technologies	Pair Corr
0.81	SRDX	SurModics Financial Report 24th of April 2024	Pair Corr
0.69	GH	Guardant Health Upward Rally	Pair Corr
0.64	CMAX	CareMax Upward Rally	Pair Corr
0.61	HCAT	Health Catalyst Financial Report 14th of May 2024	Pair Corr

The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.

The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:

How To Invest In Edwards

Details

Is Edwards Stock a good investment?

Details

What is Edwards Lifesciences' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis.

You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years

Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

2.3

Revenue Per Share

9.897

Quarterly Revenue Growth

0.138

Return On Assets

0.1225

The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Financial Ratios Analysis

Edwards Lifesciences fundamentals Correlations

Edwards Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Edwards Lifesciences fundamentals Accounts

Edwards Lifesciences Investors Sentiment

Pair Trading with Edwards Lifesciences

Moving against Edwards Stock

Complementary Tools for Edwards Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 0.98	Operating Cash Flow Per Share
Pfcf Ratio	+ 0.98	Pocfratio
Ptb Ratio	+ 0.97	Price To Sales Ratio
Pb Ratio	+ 0.97	Price To Sales Ratio

Days Of Inventory On Hand	- 0.95	Inventory Turnover
Days Payables Outstanding	- 0.88	Payables Turnover
Pb Ratio	- 0.82	Capex To Depreciation
Capex To Depreciation	- 0.82	Ptb Ratio
Pocfratio	- 0.81	Inventory Turnover
Pocfratio	- 0.79	Free Cash Flow Yield